Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
British Journal of Pharmacology|December 6, 2002
Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptorsK Flau, A Redmer, S Liedtke, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1986
Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sitesG Engel, M Göthert, D Hoyer, et al.
Neurochemistry International|January 1, 1997
Effects of imidazolines on noradrenaline release in brain: an investigation into their relationship to imidazoline, alpha 2 and H3 receptorsE Schlicker, K Fink, M Kathmann, et al.
European Journal of Pharmacology|July 13, 1984
Modulation of noradrenaline release in human saphenous vein via presynaptic alpha 2-adrenoceptorsM Göthert, E Schlicker, F Hentrich, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1994
The 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide facilitates noradrenaline release by blockade of alpha 2-adrenoceptors in the mouse brain cortexE Schlicker, M Kathmann, H J Exner, et al.
British Journal of Pharmacology|August 6, 2000
Dual interaction of agmatine with the rat alpha(2D)-adrenoceptor: competitive antagonism and allosteric activationG J Molderings, S Menzel, M Kathmann, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1992
Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein by presynaptic histamine H3 receptorsG J Molderings, G Weissenborn, E Schlicker, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1994
H3 receptor-mediated inhibition of noradrenaline release: an investigation into the involvement of Ca2+ and K+ ions, G protein and adenylate cyclaseE Schlicker, M Kathmann, M Detzner, et al.
European Journal of Pharmacology|May 19, 1989
Inhibition of noradrenaline release in the pig coronary artery via a novel serotonin receptorG J Molderings, M Göthert, K Fink, et al.
British Journal of Pharmacology|September 23, 2008
Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX productH Kozłowska, M Baranowska, E Schlicker, et al.
Pageof 13